Skip to main content
. 2022 Nov 9;37(46):e327. doi: 10.3346/jkms.2022.37.e327

Table 1. Baseline characteristics of the COPD patients according to inhaler satisfaction.

Variables Total (N = 261) High satisfaction (n = 163) Low satisfaction (n = 98) P value
Patient characteristics
Age, yr 69.8 ± 7.7 70.1 ± 7.2 69.3 ± 8.5 0.427
Male 244 (93.5) 152 (93.3) 92 (93.9) 0.843
BMI, kg/m2 23.5 ± 3.5 23.9 ± 3.2 22.9 ± 3.8 0.047
Smoking status 0.087
Never-smoker 35 (13.4) 23 (14.1) 12 (12.2)
Ex-smoker 179 (68.6) 117 (71.8) 62 (63.3)
Current-smoker 47 (18.0) 23 (14.1) 24 (24.5)
Educational level 0.272
Low (≤ 6 yr) 99 (37.9) 66 (40.5) 33 (33.7)
High (> 6 yr) 162 (62.1) 97 (59.5) 65 (66.3)
COPD characteristics
COPD duration, yr 3.6 ± 4.3 3.8 ± 4.6 3.2 ± 3.9 0.226
FEV1/FVC (%) 58.6 ± 13.7 59.3 ± 13.1 57.3 ± 14.7 0.255
Percentage predicted FEV1 63.5 ± 17.5 65.2 ± 16.2 60.7 ± 19.2 0.053
Percentage predicted DLco (n = 258) 68.4 ± 19.5 69.7 ± 19.6 66.1 ± 19.1 0.148
GOLD grade 0.041
I/II 204 (78.1) 134 (82.2) 70 (71.4)
III/IV 57 (21.9) 29 (17.8) 28 (28.6)
mMRC score 1.3 ± 0.9 1.2 ± 0.9 1.5 ± 0.8 0.008
mMRC < 2 162 (62.1) 111 (68.1) 51 (52.0) 0.010
mMRC ≥ 2 99 (37.9) 52 (31.9) 47 (48.0)
CAT 9.9 ± 5.6 9.5 ± 5.4 10.6 ± 5.8 0.140
Moderate exacerbations in the prior year 108 (41.4) 66 (40.5) 42 (42.9) 0.707
Severe exacerbations in the prior year 50 (19.2) 27 (16.6) 23 (23.5) 0.170
Inhaler characteristics
Puff burden, puffs/day 2.2 ± 1.3 2.1 ± 1.1 2.4 ± 1.4 0.093
Usage of multiple inhalers 55 (21.1) 31 (19.0) 24 (24.5) 0.294
Frequency of inhaler 0.086
Once daily 199 (76.2) 130 (79.8) 69 (70.4)
Twice daily 52 (23.8) 33 (20.2) 29 (29.6)
Adherence 0.007
Good 213 (81.6) 140 (85.9) 73 (74.5)
Partial 42 (16.1) 22 (13.5) 20 (20.4)
Poor 6 (2.3) 1 (0.6) 5 (5.1)
Previous education on inhaler use 249 (95.4) 156 (95.7) 93 (94.9) 0.768
FSI-10 44.4 ± 4.7 47.6 ± 2.1 39.1 ± 2.2 < 0.001

Data are presented as the mean ± standard deviation or number (percentage).

BMI = body mass index, CAT = chronic obstructive pulmonary disease assessment test, COPD = chronic obstructive pulmonary disease, DLco = diffusion capacity for carbon monoxide, FEV1 = forced expiratory volume in 1 second, FSI-10 = Feeling of Satisfaction with Inhaler questionnaire, FVC = forced vital capacity, GOLD = Global Initiative for Chronic Obstructive Lung Disease, mMRC = modified Medical Research Council.